Back
Xencor 10K Form
Sell
24
XNCR
Xencor
Last Price:
28.01
Seasonality Move:
2.95%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-08-05 | 10Q | XNCR/Xencor Quarterly |
2020-05-08 | 10Q | XNCR/Xencor Quarterly |
2020-02-25 | 10K | XNCR/Xencor Annual |
2019-11-05 | 10Q | XNCR/Xencor Quarterly |
2019-08-07 | 10Q | XNCR/Xencor Quarterly |
2019-05-09 | 10Q | XNCR/Xencor Quarterly |
Receive XNCR News And Ratings
See the #1 stock for the next 7 days that we like better than XNCR
XNCR Financial Statistics
Sales & Book Value
Annual Sales: | $164.58M |
---|---|
Cash Flow: | $-35.33M |
Price / Cash Flow: | 0 |
Annual Sales: | $12.13 |
Price / Book: | 2.31 |
Profitability
EPS (TTM): | -0.93000 |
---|---|
Net Income (TTM): | $-55.18M |
Gross Margin: | $0 |
Return on Equity: | -7.48% |
Return on Assets: | -6.52% |
Xencor Earnings Forecast
Key Xencor Financial Ratios
- The Gross Profit Margin over the past 4 years for XNCR is 0.00%.
- The Selling, General & Administrative Expenses for XNCR have been equal to 28.86% of Gross Profit Margin.
- The Research & Development expenses have been 121.25% of Revenue.
- The Interest Expense is -0.03% of Operating Income.
- The Net Earning history of XNCR is -33.53% of Total Revenues.
- Per Share Earnings over the last 12 years have been positive in 6 years.
Xencor Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Healthcare |
Current Symbol: | XNCR |
CUSIP: | 98401F |
Website: | xencor.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 10.58 |
Quick Ratio: | 10.21 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |